📱 Now on iPhone — live scores, valuations & alerts on the go
Download iPhone App

Beauty Health Co (SKIN)

Healthcare Model Divergence low mixed
$9.94
Updated: 2026-10-31
Next earnings: Nov 4, after close (est.)

As of October 31, 2026, TradeApes rates Beauty Health Co (SKIN) 48 out of 100 (Mixed); valuation verdict: Model Divergence.

48
TradeApes Score
Financial Strength
57 Mixed
Operating Trend
58 Mixed
Relative Value
25 Overvalued
Capital Allocation
43 Weak
Risk Management
68 Healthy
Sector Rank #126

The market price implies growth our normalized base can't support, so we don't publish a single fair-value figure for SKIN.

Key Findings
What's working
  • + Margins expanding 29.3 points — costs growing slower than sales
  • + Operating margin expanded 29.3 points over about three years — improving profitability
  • + Generates cash — not dependent on raising money
What to watch
  • − Operating profit covers interest -0.7× over — thin cover
  • − Earnings yield -0.2% (P/E about —) — no earnings to value
  • − Revenue growth about -7% a year (YoY and 3-yr blend) — sales are shrinking
AI-written analysis
The full Beauty Health Co (SKIN) analysis
Why the model reads SKIN as model divergence, the methods that voted, and what would change the verdict. Written from the same filings as the score above. How these are written
TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.
Sign up for our Weekly Sector Leaders Newsletter
11 sector-leading stocks delivered to your inbox every Sunday. Free.
No spam. Unsubscribe anytime.